This video is the study background of a collaborative Cleveland Clinic-Mayo Clinic team of researchers has shown for the first time that patients with advanced prostate cancer are more likely to die earlier from their disease if they carry a specific testosterone-related genetic abnormality.
Study Background – Testosterone-Related Genetic Mutation Leads To Deadlier Outcomes In Prostate Cancer
